Generic semaglutide widens access, but doctors warn of misuse and quality risks

A diligent walks into a session and asks not astir diabetes control, but astir value nonaccomplishment drug. He has seen the results online, heard the sanction of the drug, and now, with prices falling, wants it. Doctors accidental specified conversations are becoming progressively communal arsenic Indian pharmaceutical companies statesman rolling retired generic versions of semaglutide, a cause utilized for benignant 2 diabetes and obesity, often described arsenic the ‘magic drug’.

With the patent connected semaglutide having expired successful India, the outgo dynamics of the cause are opening to shift. Earlier, branded versions of semaglutide, chiefly marketed by multinational companies, could outgo anyplace betwixt ₹8,000 and ₹12,000 per period depending connected the dosage and formulation. With home pharmaceutical companies introducing generic versions, prices are expected to driblet by 30–60% successful the archetypal phase.